Core Viewpoint - The report outlines the financial advisory opinion of China International Capital Corporation regarding the equity change of Baowu Magnesium Industry Technology Co., Ltd, confirming compliance with relevant laws and regulations, and the accuracy of disclosed information [1][2][3]. Group 1: Financial Advisory and Compliance - The financial advisor, China International Capital Corporation, has been appointed by Baosteel Metal Co., Ltd to provide advisory services for the equity change [1]. - The advisory opinion is based on thorough investigation and adherence to industry standards, ensuring that the equity change complies with the Company Law, Securities Law, and relevant disclosure regulations [2][3]. - The financial advisor asserts that the disclosed information is true, accurate, and complete, with no misleading statements or significant omissions [2][3]. Group 2: Company Information - Baosteel Metal Co., Ltd is located at 3962 Yunchuan Road, Baoshan District, Shanghai, with a registered capital of 555,499,008.4 RMB [5][6]. - The controlling shareholder of Baosteel Metal is China Baowu Steel Group Corporation, with the actual controller being the State-owned Assets Supervision and Administration Commission of the State Council [6][7]. - The company engages in various activities including the sale of metal materials, import and export of goods, and technology services [5][6]. Group 3: Equity Change Details - Baosteel Metal plans to acquire 49,589,578 shares of Baowu Magnesium Industry, representing 5% of the total share capital [4][5]. - The acquisition includes shares held by Mei Xiaoming (40,795,963 shares, 4.11%) and Zhu Yuehai (8,793,615 shares) [4]. - The report confirms that the equity change has been disclosed in accordance with the Securities Law and relevant guidelines [5][6].

Core Viewpoint - The report outlines the equity change of Nanjing Ruilian Emerging Industry Investment Fund Partnership (Limited Partnership) in Hongsoft Technology Co., Ltd., indicating a reduction in shareholding from 16.09% to 10% due to both voluntary share reduction and passive increase from share buybacks [1][5][9]. Group 1: Equity Change Details - The equity change was driven by the need for fund arrangement, leading to a reduction in shares held by the information disclosing party [5]. - The total number of shares held before the change was 65,331,250, which represented 16.09% of the total share capital of 406,000,000 shares [6]. - After the equity change, the number of shares held decreased to 40,117,040, accounting for 10% of the current total share capital of 401,170,400 shares [6][9]. Group 2: Future Shareholding Plans - The information disclosing party plans to reduce its holdings by up to 12,035,112 shares, which is no more than 3% of the total share capital, through block trades and centralized bidding within the next 12 months [5]. - As of the report date, there is uncertainty regarding any further increase or decrease in shareholding in the next 12 months [5][9]. Group 3: Compliance and Disclosure - The information disclosing party has confirmed that the report does not contain any false records, misleading statements, or significant omissions, and it assumes legal responsibility for the accuracy and completeness of the information [2][8]. - The report has been prepared in accordance with the relevant laws and regulations, ensuring full disclosure of the equity change situation [2][5].

Core Viewpoint - The report details the equity changes of Suzhou Delong Laser Co., Ltd., indicating a reduction in shareholding by several investment centers due to funding needs, resulting in a decrease in their collective ownership from 13.55% to 10.00% [1][6][7]. Group 1: Equity Change Details - The equity change involves a total reduction of 3,674,000 shares, which represents a decrease of 3.55% in the total shareholding [7][10]. - The specific reductions include: - Beijing Woyan Investment Center reduced its holdings by 1,917,200 shares (1.85%) - Jiangyin Woyan Investment Center reduced by 1,660,000 shares (1.61%) - Wuxi Yuyuan Investment Center reduced by 1,320,000 shares (1.29%) - Suzhou Wojie Investment Center reduced by 36,800 shares (0.04%) [7][10]. Group 2: Information Disclosure Obligations - The report confirms that the information disclosure obligations have been met, with no undisclosed significant information related to the equity changes [8]. - The investment centers involved have not engaged in any other transactions involving the company's shares in the past six months, aside from the disclosed equity changes [8][9]. Group 3: Future Plans - The investment centers have indicated that they may continue to adjust their holdings within the next 12 months, adhering to relevant legal and regulatory requirements for disclosure [6][7].

Core Viewpoint - The report outlines the financial advisor's verification opinion regarding the equity change report of Shandong Pharmaceutical Glass Co., Ltd, confirming compliance with relevant laws and regulations, and the accuracy of the disclosed information [2][3][7]. Group 1: Verification of Equity Change Report - The financial advisor conducted a thorough review of the equity change report, ensuring it meets the requirements of the Securities Law and other relevant regulations [7][8]. - No false records, misleading statements, or significant omissions were found in the equity change report [3][7]. Group 2: Basic Information of Disclosing Obligors - The disclosing obligors include China International Medical Health Co., Ltd and Sinopharm International Hong Kong Co., Ltd, both of which are wholly owned subsidiaries of Sinopharm Group [5][9]. - China International Medical Health Co., Ltd has a registered capital of 500 million yuan and is a state-owned enterprise [9][10]. Group 3: Equity Structure and Control Relationships - Sinopharm International is the controlling shareholder of Sinopharm International Hong Kong, which is a wholly owned subsidiary [11][12]. - The controlling shareholder of Sinopharm International is Sinopharm Group, which has not changed in the last two years [12][14]. Group 4: Purpose of Equity Change - The equity change aims to enhance the core competitiveness of Sinopharm Group and support the development of strategic emerging industries [23][24]. - After the equity change, Sinopharm International will focus on building a world-class pharmaceutical materials industry chain [23][25]. Group 5: Financial Data of Disclosing Obligors - For the year ending December 31, 2024, China International Medical Health Co., Ltd reported total assets of 2,211,697.55 million yuan and total liabilities of 970,789.75 million yuan [16]. - Sinopharm International Hong Kong reported total assets of 279,837.80 million yuan for the same period [16].

Core Viewpoint - Guangzhou Pyramid Investment Management Co., Ltd. has reduced its shareholding in Guangdong Tongyu Communication Co., Ltd. to below 5% due to funding needs, as disclosed in the simplified equity change report [1][4]. Group 1: Shareholding Changes - The shareholding of Guangzhou Pyramid Investment Management Co., Ltd. decreased from 26,133,704 shares (5.0085%) to 26,121,604 shares (4.999987%) after a reduction of 12,100 shares [4][7]. - The reduction was executed through centralized bidding on June 24, 2025, at an average price of 14.81 yuan per share [4][7]. - The company plans to continue reducing its shares, having already disclosed a plan to sell up to 200,000 shares (0.3833% of total share capital) within 15 trading days from May 27, 2025 [4][5]. Group 2: Company Information - Guangzhou Pyramid Investment Management Co., Ltd. was established on May 24, 2011, with a registered capital of 10 million yuan and is located in Nansha District, Guangzhou [3]. - The company is not a controlling shareholder or actual controller of Guangdong Tongyu Communication Co., Ltd., and the recent equity change will not affect the company's governance structure or ongoing operations [4][7]. - The legal representative of Guangzhou Pyramid Investment Management Co., Ltd. is Zeng Dongyun, who holds a 60% stake, while Zhang Li holds 40% [3].

Core Viewpoint - The report outlines the equity changes of Wuxi Delinhai Environmental Technology Co., Ltd., indicating a reduction in the shareholding percentage of the disclosing party, Chen Hong, to 5% due to capital increase and share reduction activities [1][3]. Group 1: Equity Change Details - The equity change is attributed to a capital increase through differential allocation and a reduction in shares held by Chen Hong, resulting in a decrease in his holding percentage from 10.09% to 5.00% [4][7]. - Prior to the equity change, Chen Hong held 6,000,000 shares, which represented 10.09% of the total shares at that time, calculated based on a total share count of 59,470,000 [4][7]. - Following the changes, Chen Hong now holds 5,650,000 shares, which is 5.00% of the current total share capital [4][7]. Group 2: Future Plans and Transactions - Chen Hong has announced a plan to reduce his holdings by up to 3,390,000 shares, which is not more than 3% of the total share capital, within three months following the announcement made on May 16, 2025 [3][4]. - The report specifies that from June 9 to June 25, 2025, Chen Hong reduced his holdings by 3,258,400 shares, accounting for 2.88% of the total share capital [6][4]. - The report confirms that there are no other transactions involving the sale or purchase of shares by Chen Hong in the six months preceding the report [6].

Core Viewpoint - Beijing Beichen Industrial Co., Ltd. is increasing its shareholding in the company, reflecting confidence in its future development and long-term investment value [3][4]. Group 1: Company Overview - The company is registered in Beijing and operates as a state-owned limited liability company [2]. - The registered capital of Beijing Beichen Industrial Group is 220.81 million RMB [2]. Group 2: Shareholding Structure - Beijing Beichen Industrial Group holds 100% of the shares in Beijing Beichen Industrial Co., Ltd., with the actual controller being the State-owned Assets Supervision and Administration Commission of the Beijing Municipal Government [2][3]. - Prior to the share increase, the group held 1,161,000,031 shares, representing 34.4815% of the total share capital [5]. - After the increase, the group holds 1,179,122,931 shares, which is 35.0198% of the total share capital, indicating an increase of 18,122,900 shares or 0.5382% [5][7]. Group 3: Purpose and Future Plans - The purpose of the share increase is to support the company's sustainable and stable development while safeguarding the interests of all shareholders [3]. - The company does not rule out the possibility of further increasing its shareholding within the next 12 months [4]. Group 4: Transaction Details - The share increase was conducted through centralized bidding on the Shanghai Stock Exchange [5]. - The average transaction prices for the shares acquired were 1.28 RMB, 1.78 RMB, and 1.66 RMB for different batches [5].

Core Viewpoint - The report outlines a shareholding change in Hunan Keli Yuan New Energy Co., Ltd., where Zhejiang Xinmaijie Enterprise Management Co., Ltd. acquires 91,604,750 shares, representing 5.50% of the total share capital, from Geely Technology Group Co., Ltd. through a private transfer agreement [1][12][14]. Group 1: Shareholding Change Details - The shareholding change is a result of an agreement transfer between entities controlled by the same actual controller, without involving secondary market transactions or triggering a change in control [12][14]. - The total transfer price for the shares is set at RMB 458,023,750, with a per-share price of RMB 5.00, which is 90% of the closing price on the trading day prior to the agreement [15][16]. Group 2: Information Disclosure Obligations - The information disclosure obligations have been fulfilled according to relevant laws and regulations, ensuring that the report does not contain any false records or misleading statements [2][19]. - The report confirms that the information disclosing party has not engaged in any trading of the company's shares in the six months preceding the shareholding change [24]. Group 3: Future Intentions and Restrictions - The information disclosing party currently has no plans to increase or decrease its shareholding in the next 12 months, although adjustments may occur [12][22]. - There are restrictions in place preventing the information disclosing party from reducing its shareholding within 12 months following the transfer [16].

Core Viewpoint - The report outlines the equity changes of Shandong Pharmaceutical Glass Co., Ltd. (stock code: 600529) and the involvement of China International Medical and Health Co., Ltd. and Sinopharm International Hong Kong Co., Ltd. in the investment and control of the company [1][2]. Group 1: Equity Changes - The equity change has been approved by the decision-making bodies of Luzhong Investment, Sinopharm International, and Sinopharm Group's board of directors [2]. - The equity change requires further approval from the relevant state-owned asset supervision authorities and the State Council's State-owned Assets Supervision and Administration Commission [2]. - The transaction will result in Sinopharm International controlling Luzhong Investment, thereby indirectly holding a 15% stake in Shandong Pharmaceutical Glass, changing the actual controller from Yiyuan County Finance Bureau to Sinopharm Group [4]. Group 2: Information Disclosure Obligations - The report confirms that the information disclosure obligations have been fully met according to the relevant laws and regulations, ensuring no false records or misleading statements exist [2][4]. - The report specifies that no other parties have been authorized to provide information or explanations not included in the report [2]. Group 3: Company Overview - Shandong Pharmaceutical Glass Co., Ltd. is listed on the Shanghai Stock Exchange and specializes in pharmaceutical glass products [1]. - The report includes detailed information about the controlling shareholders and the corporate structure of the involved parties, including their registered capital and business scope [5][6]. Group 4: Financial Overview - Sinopharm International's recent financial data shows total assets of approximately 2,211.70 million and total liabilities of about 970.79 million as of December 31, 2024 [9]. - The revenue for Sinopharm International was approximately 2,048.48 million, with a net profit of around 34.55 million for the same period [9].

Core Viewpoint - The report outlines the equity change of Chengdu Xingrong Environment Co., Ltd., indicating a reduction in shareholding by the information disclosing parties due to their financial planning needs [1][7]. Group 1: Company Information - Chengdu Xingrong Environment Co., Ltd. is listed on the Shenzhen Stock Exchange with the stock code 000598 [1]. - The information disclosing parties include Changjiang Ecological Environmental Group Co., Ltd. and Three Gorges Capital Holding Co., Ltd. [1][5]. Group 2: Shareholding Changes - As of the report date, the information disclosing parties collectively held 456,337,297 shares, representing 15.29% of the total share capital of 2,984,434,721 shares [8]. - The shareholding of Changjiang Ecological Environmental Group decreased from 91,041,592 shares (3.05%) to 78,416,731 shares (2.63%) after a reduction of 12,624,861 shares, resulting in a total reduction of 0.42% [8][9]. Group 3: Future Plans - The information disclosing parties do not rule out the possibility of further increasing or decreasing their holdings in Chengdu Xingrong Environment within the next 12 months [7][8].